tiprankstipranks

Et al BioCapital Profile - Seeking Alpha Blogger

4 Followers
tipranks
Et al BioCapital

Et al BioCapital
Seeking Alpha

Financial Blogger
#1,826 out of 28,561 Financial Bloggers
#3,178 out of 37,344 experts

Success Rate

33%
3 out of 9 ratings made a profit

Average Return

+61.00%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Et al BioCapital's trades since 2019 and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of 61.0% per rating.

Stock Rating Distribution

9Ratings
77.78% Bullish
22.22% Bearish
0.00% Neutral
Distribution of Et al BioCapital's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Vericel Corporation
(VCEL)
Rating:Buy
Date:Mar 23, 2020 - Mar 23, 2021
Return:+650.90%
The most profitable rating made by Et al BioCapital

Et al BioCapital's Stock Coverage

Company Name
Date
Position
No. of Ratings
Success Rate
Avg Return
PolarityTE
Oct 15, 2019
Bearish
1Ratings
100%
+65.30%
Adicet Bio
Nov 12, 2019
Bearish
1Ratings
100%
+80.70%
Evolus
Jan 13, 2020
Bullish
1Ratings
0%
-51.90%
Vericel
Mar 23, 2020
Bullish
1Ratings
100%
+650.90%
Gilead Sciences
Jun 20, 2020
Bullish
1Ratings
0%
-10.20%
Meiragtx Holdings
Aug 24, 2020
Bullish
1Ratings
0%
-4.20%
Korro Bio
Sep 17, 2020
Bullish
1Ratings
0%
-71.00%
Omeros
Oct 14, 2020
Bullish
1Ratings
0%
-28.10%
Cellectis SA
Jul 13, 2021
Bullish
1Ratings
0%
-82.50%
List of latest recommendations made by Et al BioCapital. Click to expand and see Et al BioCapital's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.